Julianna Piskorz

Julianna Piskorz, Katarzyna Kobalczyk, Mihaela van der Schaar

Large Language Models (LLMs) have recently been successfully applied to regression tasks -- such as time series forecasting and tabular prediction -- by leveraging their in-context learning abilities. However, their autoregressive decoding process may be ill-suited to continuous-valued outputs, where obtaining predictive distributions over numerical targets requires repeated sampling, leading to high computational cost and inference time. In this work, we investigate whether distributional properties of LLM predictions can be recovered without explicit autoregressive generation. To this end, we study a set of regression probes trained to predict statistical functionals (e.g., mean, median, quantiles) of the LLM's numerical output distribution directly from its internal representations. Our results suggest that LLM embeddings carry informative signals about summary statistics of their predictive distributions, including the numerical uncertainty. This investigation opens up new questions about how LLMs internally encode uncertainty in numerical tasks, and about the feasibility of lightweight alternatives to sampling-based approaches for uncertainty-aware numerical predictions.

Usman Anwar, Julianna Piskorz, David D. Baek et al.

Large language models are beginning to show steganographic capabilities. Such capabilities could allow misaligned models to evade oversight mechanisms. Yet principled methods to detect and quantify such behaviours are lacking. Classical definitions of steganography, and detection methods based on them, require a known reference distribution of non-steganographic signals. For the case of steganographic reasoning in LLMs, knowing such a reference distribution is not feasible; this renders these approaches inapplicable. We propose an alternative, \textbf{decision-theoretic view of steganography}. Our central insight is that steganography creates an asymmetry in usable information between agents who can and cannot decode the hidden content (present within a steganographic signal), and this otherwise latent asymmetry can be inferred from the agents' observable actions. To formalise this perspective, we introduce generalised $\mathcal{V}$-information: a utilitarian framework for measuring the amount of usable information within some input. We use this to define the \textbf{steganographic gap} -- a measure that quantifies steganography by comparing the downstream utility of the steganographic signal to agents that can and cannot decode the hidden content. We empirically validate our formalism, and show that it can be used to detect, quantify, and mitigate steganographic reasoning in LLMs.

Julianna Piskorz, Cristina Pinneri, Alvaro Correia et al.

Masked Diffusion Language Models (MDLMs) have recently emerged as a promising alternative to Autoregressive Language Models (ARLMs), leveraging a denoising objective that, in principle, should enable more uniform context utilisation. In this work, we examine the context comprehension abilities of MDLMs and uncover two key limitations. First, despite their more global training objective and bidirectional attention mechanism, similarly to ARLMS, MDLMs exhibit a strong locality bias: performance is highly sensitive to the position of relevant information within the input, favouring local over distant context. Second, we show that appending a large number of mask tokens--required for generation--can significantly degrade context comprehension. Through systematic ablations, we find that these masks act as distractors, reducing the model's ability to process relevant information. To address this, we introduce a mask-agnostic loss function that encourages predictions to remain invariant to the number of appended masks. Fine-tuning with this objective substantially mitigates the distracting effect of masks, improving robustness of MDLMs. Overall, our findings reveal critical limitations of the current MDLM training paradigm and provide actionable insights for building diffusion-based language models with stronger context comprehension.

Jeroen Berrevoets, Julianna Piskorz, Robert Davis et al.

Estimating treatment effects (TE) from observational data is a critical yet complex task in many fields, from healthcare and economics to public policy. While recent advances in machine learning and causal inference have produced powerful estimation techniques, their adoption remains limited due to the need for deep expertise in causal assumptions, adjustment strategies, and model selection. In this paper, we introduce CATE-B, an open-source co-pilot system that uses large language models (LLMs) within an agentic framework to guide users through the end-to-end process of treatment effect estimation. CATE-B assists in (i) constructing a structural causal model via causal discovery and LLM-based edge orientation, (ii) identifying robust adjustment sets through a novel Minimal Uncertainty Adjustment Set criterion, and (iii) selecting appropriate regression methods tailored to the causal structure and dataset characteristics. To encourage reproducibility and evaluation, we release a suite of benchmark tasks spanning diverse domains and causal complexities. By combining causal inference with intelligent, interactive assistance, CATE-B lowers the barrier to rigorous causal analysis and lays the foundation for a new class of benchmarks in automated treatment effect estimation.

Harry Amad, Zhaozhi Qian, Dennis Frauen et al.

Causal inference is essential for developing and evaluating medical interventions, yet real-world medical datasets are often difficult to access due to regulatory barriers. This makes synthetic data a potentially valuable asset that enables these medical analyses, along with the development of new inference methods themselves. Generative models can produce synthetic data that closely approximate real data distributions, yet existing methods do not consider the unique challenges that downstream causal inference tasks, and specifically those focused on treatments, pose. We establish a set of desiderata that synthetic data containing treatments should satisfy to maximise downstream utility: preservation of (i) the covariate distribution, (ii) the treatment assignment mechanism, and (iii) the outcome generation mechanism. Based on these desiderata, we propose a set of evaluation metrics to assess such synthetic data. Finally, we present STEAM: a novel method for generating Synthetic data for Treatment Effect Analysis in Medicine that mimics the data-generating process of data containing treatments and optimises for our desiderata. We empirically demonstrate that STEAM achieves state-of-the-art performance across our metrics as compared to existing generative models, particularly as the complexity of the true data-generating process increases.

Julianna Piskorz, Krzysztof Kacprzyk, Harry Amad et al.

The Average Treatment Effect (ATE) is a foundational metric in causal inference, widely used to assess intervention efficacy in randomized controlled trials (RCTs). However, in many applications -- particularly in healthcare -- this static summary fails to capture the nuanced dynamics of treatment effects that vary with both dose and time. We propose a framework for modelling treatment effect trajectories as smooth surfaces over dose and time, enabling the extraction of clinically actionable insights such as onset time, peak effect, and duration of benefit. To ensure interpretability, robustness, and verifiability -- key requirements in high-stakes domains -- we adapt SemanticODE, a recent framework for interpretable trajectory modelling, to the causal setting where treatment effects are never directly observed. Our approach decouples the estimation of trajectory shape from the specification of clinically relevant properties (e.g., maxima, inflection points), supporting domain-informed priors, post-hoc editing, and transparent analysis. We show that our method yields accurate, interpretable, and editable models of treatment dynamics, facilitating both rigorous causal analysis and practical decision-making.

Mihaela van der Schaar, Richard Peck, Eoin McKinney et al.

This manifesto represents a collaborative vision forged by leaders in pharmaceuticals, consulting firms, clinical research, and AI. It outlines a roadmap for two AI technologies - causal inference and digital twins - to transform clinical trials, delivering faster, safer, and more personalized outcomes for patients. By focusing on actionable integration within existing regulatory frameworks, we propose a way forward to revolutionize clinical research and redefine the gold standard for clinical trials using AI.